LIVN Q4 2023 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$310M+12.8% YoY

Gross Profit

$190M61.3% margin

Operating Income

-$88M-28.4% margin

Net Income

$16M5.3% margin

EPS (Diluted)

$0.30

QoQ Revenue Growth

+8.4%

Cash Flow

Operating Cash Flow

$54M

Free Cash Flow

$41M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.2B

Stockholders' Equity

$1.3B

Cash & Equivalents

$267M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$310M	$275M	+12.8%
Gross Profit	$190M	$184M	+3.6%
Operating Income	-$88M	$14M	-730.3%
Net Income	$16M	$2M	+883.7%

Revenue Segments

Cardiopulmonary Segment

$161M52%

Neuromodulation Segment

$137M44%

Advanced Circulatory Support Segment

$10M3%

Geographic Segments

UNITED STATES

$173M56%

Locations Excluding The United States And Europe

$74M24%

Europe

$63M20%